Tardive Dyskinesia & Movement Disorders: Conference Sessions

11 sessions at 6 meetings. TD, drug-induced parkinsonism, akathisia, VMAT2 inhibitors.

Meetings covering tardive dyskinesia & movement disorders

AACAP Annual Meeting 2026	October 26–31, 2026	3 sessions →
NEI Fall Congress 2026	November 5–8, 2026	3 sessions →
MGH 50th Annual Psychopharmacology Conference	October 16–18, 2026	1 session →
Medical Psychiatry: Comprehensive Update Conference 2026	September 17–20, 2026 (past)	2 sessions →
39th ECNP Congress	October 10–13, 2026 (past)	1 session →
Psych Congress 2026	September 15–19, 2026 (past)	1 session →

October 16–18, 2026 · Boston, MA

LectureManagement of Side-Effects of Antipsychotics
Abigail Donovan
Preventing and treating the metabolic, motor, and other adverse effects of antipsychotic medications.
Antipsychotic Prescribing GLP-1 & Metabolic Psychiatry

October 26–31, 2026 · Atlanta, GA

LectureNeurological Side Effects of Psychotropic Medications in Children and Adolescents: Recognition, Management, and Clinical Implications
Raman Baweja
Covers recognizing and managing neurological adverse effects of psychotropics in young patients.
Child & Adolescent Drug Interactions & Safety
LectureFunctional Neurological Disorder as Somatic Distress in Youth: Integrating Neurology and Psychiatry
Natalia Szejko
Looks at functional neurological disorder in youth as a form of somatic distress and how neurology and psychiatry can collaborate.
Child & Adolescent Medical Comorbidity & C-L Psychiatry
LectureDifferentiating Tics and Functional Tic-Like Behaviors
Julio Quezada
Addresses how to distinguish true tics from functional tic-like behaviors.
Autism & Neurodevelopmental Disorders Child & Adolescent

November 5–8, 2026 · Colorado Springs, CO

SymposiumSeen and Unseen: The Hidden Toll of Tardive Dyskinesia
Hara E. Oyedeji
Explores the functional and psychosocial burden of tardive dyskinesia and how to screen, assess, and monitor for it.
SessionAIMS Demonstration
Leslie Citrome · Hara E. Oyedeji
Live demonstration of how to administer the Abnormal Involuntary Movement Scale in practice.
Measurement-Based Care & Diagnosis
SymposiumSteady Hands, Steady Minds: From Evidence to Empowerment in TD Treatment
Leslie Citrome
Reviews the neurobiological rationale and clinical evidence behind current tardive dyskinesia treatments.
Neuroscience & Mechanisms

October 10–13, 2026 · Munich, Germany

SymposiumMS04 – EAN Mini Symposium – Rethinking the psychiatric approach in neurology conditions: in case of movement disorders
Anna Rita Bentivoglio · Jaime Kulisevsky
Joint neurology session on psychiatric management in Huntington's disease and Parkinson's disease psychosis.
Schizophrenia & Psychosis Medical Comorbidity & C-L Psychiatry

September 17–20, 2026 · Online

LecturePsychiatric Emergencies: Catatonia, NMS, Serotonin Syndrome
Nathan Praschan
Recognition and treatment of the major life-threatening neuropsychiatric syndromes seen in hospitalized patients.
Catatonia Drug Interactions & Safety Emergency & Acute Psychiatry
LectureNeuropsychiatry of Movement Disorders
Stanley Lyndon
Psychiatric symptoms in Parkinson disease and other movement disorders and their treatment.
Medical Comorbidity & C-L Psychiatry

September 15–19, 2026 · New Orleans, LA

SymposiumMasterClass: AIMS Is Nothing but a Number: Focusing on Function and Family in Tardive Dyskinesia
Rebecca Barbee
Reframes tardive dyskinesia care around function and quality of life rather than rating scales alone, reviewing recognition, differential diagnosis, and VMAT2 inhibitor evidence.